The national distinction recognizes VBH’s work to safeguard patients from preventable harm and errors.

Science Immunology study suggests a new class of inborn errors of immunometabolism and could improve care for patients with these complex diseases.

The new study identifies 4,248 CpG sites associated with the risk of seven different types of cancer: breast, colorectal, renal cell, lung, ovarian, prostate and testicular germ cell cancers.

A kidney protein that responds to low levels of blood potassium — which can cause high blood pressure and cardiovascular problems — may be a target for new therapeutics.

The presentations will be held from 10 a.m. to 3 p.m. in room 202 Light Hall and are open to the public.